Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

48.61
Delayed Data
As of Apr 09
 -0.56 / -1.14%
Today’s Change
40.32
Today|||52-Week Range
58.59
+15.46%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Mellett Paul J
Chief Financial Officer & Treasurer
Sale1/08/20216,000$45.58$273.5K+6.88%
Luly Jay R
President & Chief Executive Officer
Sale12/15/20202,201$42.52$93.6K+13.85%
Or Yat Sun
Chief Science Officer & Senior Vice President
Buy1/26/20215,149$14.18$73.0K-0.33%
Or Yat Sun
Chief Science Officer & Senior Vice President
Sale12/15/20201,540$42.52$65.5K+13.85%
Adda Nathalie
Chief Medical Officer & Senior Vice President
Sale12/15/20201,540$42.52$65.5K+13.85%
Gardiner Nathaniel S
General Counsel & Senior Vice President
Sale12/15/20201,540$42.52$65.5K+13.85%
Or Yat Sun
Chief Science Officer & Senior Vice President
Buy1/26/20214,872$11.77$57.3K-0.33%
Gardiner Nathaniel S
General Counsel & Senior Vice President
Buy12/03/20201,667$30.00$50.0K+16.46%
Or Yat Sun
Chief Science Officer & Senior Vice President
Buy1/26/20213,672$11.77$43.2K-0.33%
Mellett Paul J
Chief Financial Officer & Treasurer
Sale12/15/2020770$42.52$32.7K+13.85%
Page of 3